Oligonucleotide-Encoded Library Screening via Single-Molecule Sequencing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional drug discovery methods face challenges in identifying active compounds from high-complexity libraries due to biases introduced by nucleic acid amplification processes, leading to the selection of compounds lacking desired biological activity.
Innovation Solution
A method utilizing a massively parallel sequencing approach and a unique tagging system that eliminates biases by performing single-step selection and enrichment, allowing for the identification of compounds binding to biological targets without the need for nucleic acid amplification, and enabling the determination of structure-activity relationships through oligonucleotide-encoded combinatorial libraries.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional multi-step selection processes with nucleic acid amplification are used, then compounds can be identified from combinatorial libraries, but biases are introduced leading to selection of compounds lacking desired biological activity
Solution Approach 1:
The patent removes the problematic nucleic acid amplification step from the identification process. By using single-molecule sequencing technology, the method directly sequences individual DNA tags attached to library members without requiring PCR amplification, thereby eliminating the biases introduced by amplification while maintaining the ability to identify active compounds from complex libraries
Solution Approach 2:
The patent replaces the biochemical amplification mechanism (PCR) with a direct physical detection mechanism (single-molecule sequencing). This substitution eliminates the need for enzymatic amplification and associated biases, allowing for more accurate and reliable identification of compounds with desired biological activity
2Productivity
If high-complexity libraries with 10^5 or more distinct compounds are synthesized, then the probability of finding active molecules increases, but the concentration of individual library members decreases making identification more difficult
Solution Approach 1:
The patent uses DNA tags as information copies that can be directly read by sequencing technology. Each library member carries a unique DNA tag that serves as a readable identifier, allowing high-throughput identification of individual compounds even at low concentrations within complex libraries of 10^5 or more members
Solution Approach 2:
The patent changes the detection parameter from bulk amplification signals to single-molecule sequencing signals. This parameter change enables the direct detection and identification of individual library members at very low concentrations, maintaining measurement precision even as library complexity increases to 10^5 or more distinct compounds
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables accurate identification of compounds with desired biological activity and facilitates the analysis of related compounds with familial structural relationships, improving the efficiency of drug discovery by reducing biases and simplifying the screening process.
Implementation Method 1
reacting the initial oligonucleotide in each aliquot with one of a set of r distinct incoming oligonucleotides in the presence of an enzyme which catalyzes the ligation of the incoming oligonucleotide and the initial oligonucleotide
Data Source
AI summary
The present invention provides a method for identifying a compound of interest by screening libraries of molecules which include an encoding oligonucleotide tag.